Neogen Corp (NEOG) — Analysis Summary
Neogen Corp (NEOG) has a market cap of $2.56B with year-over-year revenue growth of -2.7%. Net margin stands at -0.9%. The stock trades at a P/E ratio of -324.1.
Key Takeaways
- Revenue changed -2.7% year-over-year
- Net margin of -0.9%
- P/E ratio of -324.1
Compared to other companies in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector, NEOG posted revenue growth of -2.7% and trades at a P/E of -324.1.
Neogen Corp (NEOG)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Debt/EBITDA at 8.4x — highly leveraged, potential refinancing risk
Interest coverage at -0.9x — earnings do not cover interest payments
Neogen Corp is develop, manufacture and market a diverse line of products and services dedicated to food and animal safety. Its Food Safety segment consists mainly of diagnostic test kits and complementary products (e.g., culture media) sold to food and animal feed producers and processors to preserve the safety and quality of food to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. These products also ensure the general hygiene of the food manufacturing environment. It also have products to determine food quality and nutritional components. Its segments are Food, Animal safety. Majority of revenue comes from Food Safety. It has presence in United states, and International market.
Sector
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Employees
1,257
Headquarters
LANSING, MI
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.